Trial Profile
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2024
Price :
$35
*
At a glance
- Drugs Durvalumab (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Bone metastases; Brain metastases; Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms Camel-01
- 22 Apr 2024 New trial record